At a glance
ClinicalIndex Comparison RecordN/ACompleted· 574 enrolled
Drug / intervention
MiniMed™ 780G Insulin Pump systemdevice
Likely dose
MiniMed™ 780G Insulin Pump systemfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
In Brief
A clinical study evaluating MiniMed™ 780G Insulin Pump system for Type 2 Diabetes Treated With Insulin. Completed, enrolled 574 participants across 31 sites.
Detailed Summary
The objective of the study is to assess the safety and effectiveness of MiniMed™ 780G system in adult subjects with insulin-requiring type 2 diabetes in a home setting. The combined run-in period and study period will be approximately 135 days long.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Treated With Insulin
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedFeb 2022
Enrollment StartFeb 2022
Primary CompletionJan 2025
TodayJul 2026
First PostedFeb 14, 2022
Enrollment StartFeb 25, 2022
Primary CompletionJan 11, 2025
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.4 years ago
Interventions
MiniMed™ 780G Insulin Pump systemdevice
MiniMed 780G insulin pump with Guardian 4 sensor (phase 1) MiniMed™ 780G BLE 2.0 insulin pump used in combination with Disposable Sensor 5 (phase 2)